Vincerx Pharma, Inc. Common Stock Financial Flexibility Index
Vincerx Pharma, Inc. Common Stock financial flexibility index. Vincerx Pharma, Inc. Common Stock (VINC) has a Financial Flexibility Index of -1.70x as of March 2025. Free cash flow of $-4.45 Million (operating CF $-4.45 Million minus capex $0.00) represents -2% of total liabilities ($2.62 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vincerx Pharma, Inc. Common Stock (2019–2024)
Financial flexibility index of Vincerx Pharma, Inc. Common Stock from 2019 to 2024. Historical Financial Flexibility Index trend for Vincerx Pharma, Inc. Common Stock across 6 annual periods. Explore Vincerx Pharma, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Vincerx Pharma, Inc. Common Stock Financial Flexibility Index by Year (2019–2024)
Vincerx Pharma, Inc. Common Stock financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Vincerx Pharma, Inc. Common Stock. For the full cash flow conversion analysis, see how efficiently does Vincerx Pharma, Inc. Common Stock generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.95x | $-26.13 Million | $-26.13 Million | $5.28 Million | ▲ +14.5% |
| 2023 | -5.78x | $-40.45 Million | $-40.45 Million | $7.00 Million | ▼ -12.7% |
| 2022 | -5.13x | $-59.60 Million | $-59.60 Million | $11.62 Million | ▼ -216.4% |
| 2021 | -1.62x | $-28.14 Million | $-33.40 Million | $17.36 Million | ▼ -341.7% |
| 2020 | -0.37x | $-2.02 Million | $-2.28 Million | $5.50 Million | ▼ -107.2% |
| 2019 | 5.07x | $223.00K | $-35.00K | $44.00K | — |